Elevance Health Inc. (ELV) Stock Price: $424.43+6.28 (+1.50%)
The total return cagr for Elevance Health Inc. (ELV) stock is 11.28% over the past 12 months. The 3 year average growth rate is -1.89% and the 5 year cagr is 3.31%. Total return includes dividends reinvested.
The closing share price for Elevance Health Inc. (ELV) stock was $424.43 for Tuesday, June 9, 2026, up +1.50% from the previous day.
ELV Price Chart
ELV Key Metrics
See All MetricsELV Earnings Preview
Next Earnings Date
Jul 16, 2026
37 days away
EPS Estimate
6.20
Revenue Est.
$48.80B
Last Quarter Results
EPS
$12.58
vs Estimate
$10.81
Revenue
$49.49B
vs Estimate
$48.20B
ELV Analyst Ratings
Consensus Rating
Based on 21 analysts
Average Price Target
$415.81
-2.0% downside
Low
$331.00
Current
$424.43
High
$498.00
ELV Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $12.07 | N/A | 8 |
| Q2 2027 | N/A | $7.17 | N/A | 8 |
| Q3 2027 | N/A | $6.09 | N/A | 13 |
| Q4 2027 | N/A | $4.00 | N/A | 8 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $29.24 | N/A | 16 |
| FY 2028 | N/A | $34.09 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $49.67B | N/A | 8 |
| Q2 2027 | N/A | $49.64B | N/A | 8 |
| Q3 2027 | N/A | $50.16B | N/A | 13 |
| Q4 2027 | N/A | $49.63B | N/A | 8 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $199.72B | N/A | 16 |
| FY 2028 | N/A | $210.04B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
ELV Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1ELV | $92.17B | $424.43 | +1.50% | +11.28% | +3.31% | +13.76% |
ELV Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt